Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OptumRx
Payers
AMA flags rising PBM concentration
Analysts note that the concentration of PBM markets increased from 82% in 2022 to 94% in 2024.
Cailey Gleeson
Sep 29, 2026 4:00pm
Why payers should have these 3 pipeline drugs on their radar
Aug 3, 2026 3:38pm
Jefferson Health sues drugmakers, PBMs over insulin prices
Jan 8, 2026 3:00pm
Optum Rx rolls out new brand drug pricing model for pharmacies
Sep 17, 2025 3:55am
CalPERS swaps OptumRx for Caremark in risk-based PBM contract
Jul 15, 2025 4:52pm
Independent pharmacies can now directly contract with GoodRx
Jun 9, 2025 9:00am
